MP
Elite in Peripheral Neuropathy
Check Dr. Michael J. Polydefkis' experience treating your condition:
About Dr. Michael J. Polydefkis

Michael Polydefkis is a Neurologist in Baltimore, Maryland. Polydefkis has been practicing medicine for over 30 years and is rated as an Elite expert by MediFind in the treatment of Peripheral Neuropathy. He is also highly rated in 18 other conditions, according to our data. His top areas of expertise are Peripheral Neuropathy, Familial Transthyretin Amyloidosis, Transthyretin Amyloidosis, and Primary Amyloidosis. He is licensed to treat patients in Maryland. Polydefkis is currently accepting new patients.

His clinical research consists of co-authoring 89 peer reviewed articles and participating in 1 clinical trial in the past 15 years. In particular, he has co-authored 33 articles and participated in 1 clinical trial in the study of Peripheral Neuropathy.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Michael J. Polydefkis it is best to call his office and ask if your insurance is accepted.

Accepts Medicare
Locations
600 N Wolfe St, Baltimore, MD 21287
Background & Education
Graduate Institution
Johns Hopkins University School Of Medicine, 1993
Specialties
Neurology
Licenses
Psychiatry & Neurology in MD
Hospital Affiliations
Howard County General Hospital
Johns Hopkins Bayview Medical Center
The Johns Hopkins Hospital
ChristianaCare - Union Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

An Open-Label Trial of Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)
90 Total Publications

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Elite
Distinguished